Clinical trial
Carboplatin in Treating Patients With Stage IC-IV Ovarian, Fallopian Tube, or…
NCT00098878 · NHS Greater Glasgow and Clyde, Other · Completed
Key facts
| NCT number | NCT00098878 |
|---|---|
| Title | Carboplatin in Treating Patients With Stage IC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer |
| Official title | SCOTROC 4: A Prospective, Multicentre, Randomised Trial Of Carboplatin Flat Dosing Vs Intrapatient Dose Escalation In First Line Chemotherapy Of Ovarian, Fallopian Tube And Primary Peritoneal Cancers |
| Lead sponsor | NHS Greater Glasgow and Clyde, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer |
| Intervention type | Drug |
| Interventions | carboplatin |
| Enrollment | 1,300 |
| Start date | Mar 1, 2004 |
| Primary completion | Jul 1, 2010 |
| Completion | Jul 1, 2010 |
| First posted | Dec 9, 2004 |
| Last update posted | Aug 7, 2013 |
| Countries | Australia, New Zealand, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: